1. Home
  2. INVZ vs IVA Comparison

INVZ vs IVA Comparison

Compare INVZ & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • IVA
  • Stock Information
  • Founded
  • INVZ 2016
  • IVA 2011
  • Country
  • INVZ Israel
  • IVA France
  • Employees
  • INVZ N/A
  • IVA N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • IVA Health Care
  • Exchange
  • INVZ Nasdaq
  • IVA Nasdaq
  • Market Cap
  • INVZ 114.2M
  • IVA 117.3M
  • IPO Year
  • INVZ N/A
  • IVA 2020
  • Fundamental
  • Price
  • INVZ $1.15
  • IVA $2.35
  • Analyst Decision
  • INVZ Buy
  • IVA Strong Buy
  • Analyst Count
  • INVZ 6
  • IVA 4
  • Target Price
  • INVZ $3.81
  • IVA $13.25
  • AVG Volume (30 Days)
  • INVZ 6.1M
  • IVA 9.3K
  • Earning Date
  • INVZ 11-13-2024
  • IVA 09-25-2024
  • Dividend Yield
  • INVZ N/A
  • IVA N/A
  • EPS Growth
  • INVZ N/A
  • IVA N/A
  • EPS
  • INVZ N/A
  • IVA N/A
  • Revenue
  • INVZ $33,158,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • INVZ $18.38
  • IVA N/A
  • Revenue Next Year
  • INVZ $244.43
  • IVA $361.78
  • P/E Ratio
  • INVZ N/A
  • IVA N/A
  • Revenue Growth
  • INVZ 339.99
  • IVA N/A
  • 52 Week Low
  • INVZ $0.45
  • IVA $1.53
  • 52 Week High
  • INVZ $2.82
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 69.41
  • IVA 36.64
  • Support Level
  • INVZ $1.05
  • IVA $2.22
  • Resistance Level
  • INVZ $1.37
  • IVA $2.39
  • Average True Range (ATR)
  • INVZ 0.14
  • IVA 0.10
  • MACD
  • INVZ 0.05
  • IVA -0.03
  • Stochastic Oscillator
  • INVZ 70.98
  • IVA 24.76

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: